ABT ABBOTT LABORATORIES

2026Q1 · CUSIP 002824100 · Sector: Healthcare & Biotech

Danger · Dual-confirm: breadth + price

Holders

3,079

Δ holders QoQ

-198

Breadth percentile

Top 100%

Whale holders

356

Δ whales

-1

Inst. holding value

$138.5B

New positions

179

Closed positions

377

Price momentum (1Q)

-21.2%

Put / Call

41/42

Breadth history (34 quarters)

Past Lit Events & Aftermath 22 lit events

Period	Percentile	Next-1Q return	Next-2Q return
2025Q4	Top 3%	-21.2%	—
2025Q2	Top 19%	+0.7%	-12.2%
2025Q1	Top 0%	-2.7%	-3.2%
2024Q4	Top 2%	+4.6%	+1.7%
2024Q3	Top 9%	+15.6%	+13.2%
2024Q1	Top 14%	+8.1%	+12.5%
2023Q4	Top 1%	-8.2%	-0.8%
2023Q2	Top 7%	-6.6%	+9.8%
2022Q4	Top 1%	+2.8%	-1.3%
2021Q4	Top 1%	-8.5%	-10.3%
2021Q3	Top 5%	-5.2%	-13.2%
2021Q1	Top 8%	+7.2%	+10.9%
2020Q4	Top 1%	-8.5%	-1.9%
2020Q3	Top 2%	+10.8%	+3.2%
2020Q2	Top 1%	+12.2%	+27.3%
2019Q4	Top 1%	+2.0%	+14.2%
2019Q3	Top 8%	+5.4%	+7.8%
2019Q2	Top 10%	-0.4%	+5.7%
2019Q1	Top 6%	+12.0%	+11.6%
2018Q4	Top 1%	+1.4%	+15.0%
2018Q3	Top 1%	+4.8%	+6.8%
2018Q1	Top 1%	+5.5%	+14.7%

Show all 22 events

Options Sentiment

Put holders

QoQ: +3

Call holders

QoQ: +7

See methodology →

Fundamentals

PE (TTM)

28.2

EPS (TTM)

$3.57

EPS YoY

-53.6%

Revenue (TTM)

$45.1B

Revenue YoY

+6.6%

Net margin

13.9%

ROE

12.1%

Debt ratio

52.9%

FCF (TTM)

$7.4B

Dividend (TTM)

$2.44

Quarterly Revenue & EPS (4Y)

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

P/E (TTM) over time

P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden

As of 2026-03-31 · SEC filings (XBRL)

Get the next update

2026Q2 holdings publish around Aug 15 — subscribe to receive the lists first.